Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-29Clinical Trial Update: Assessment of Periodic Screening of Women With Denser Breast Using WBUS and DBT [NA]
Clinical trial update on periodic screening of women with dense breasts using WBUS and DBT; study completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer [Phase 2]
Phase 2 trial update of pertuzumab plus trastuzumab and nab-paclitaxel (albumin-stabilized nanoparticle paclitaxel) for HER2-positive advanc…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients [Phase 2]
Phase 2 clinical trial update evaluating metronomic oral chemotherapy with cyclophosphamide, capecitabine, and vinorelbine in metastatic/met…
-
CLINICAL_TRIALS trial_result · 2023-06-28Clinical Trial Update: Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users [Phase 3]
Phase III randomized trial comparing low-dose tamoxifen to placebo in hormone replacement therapy users for breast cancer risk reduction.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer [Phase 3]
Phase 3 trial evaluating tamoxifen citrate, letrozole, anastrozole, or exemestane with or without chemotherapy in invasive breast cancer (Rx…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY） [Phase 1, Phase 2]
A Phase 1/2 trial investigating targeted antibody-drug conjugates for HER2 ultra-low or no expression in advanced breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer [Phase 3]
A Phase 3 trial comparing EC-THP versus TCbHP in HER2-positive, lymph node–positive, early breast cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02] [Phase 3]
Phase 3 DESTINY-Breast02 trial of Enhertu (trastuzumab deruxtecan, DS-8201a) in pre-treated unresectable or metastatic HER2-positive breast …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial) [Phase 3]
A Phase 3 clinical trial (Rosy Trial) evaluating Disitamab Vedotin ( RC48 ) in HR-positive, HER2-low metastatic breast cancer is currently r…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Phase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA) [Phase 2]
Phase 2 study assessing Imprime PGG in combination with pembrolizumab in HR+/HER2- metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related Toxicity [Phase 3]
A Phase 3 trial comparing amcenestrant to tamoxifen in hormone receptor-positive early breast cancer patients who discontinued aromatase inh…
-
CLINICAL_TRIALS trial_result · 2023-06-18Clinical Trial Update: Chemotherapy in Treating Women With Previously Treated Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy in women with previously treated metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04] [Phase 3]
Phase 3 DESTINY-Breast04 trial evaluating trastuzumab deruxtecan versus investigator's choice in HER2-low breast cancer; results were posted…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery [Phase 3]
Phase 3 trial evaluating hypofractionated radiation therapy to reduce recurrence in patients with breast cancer after surgery; results have …
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer [Phase 2]
Phase 2 trial evaluating preoperative fulvestrant with or without enzalutamide in ER-positive, HER2-negative breast cancer; registry indicat…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer [Phase 3]
Phase 3 trial update evaluating paclitaxel with or without bevacizumab in locally recurrent or metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer [Phase 3]
Phase 3 trial evaluating hormone replacement therapy for hot flashes and vaginal symptoms in postmenopausal women on tamoxifen for breast ca…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Women With Stage II or Stage IIIA Breast Cancer That Has Spread to the Lymph Nodes [Phase 3]
Phase 3 trial update on combination chemotherapy for women with stage II/IIIA breast cancer that has spread to lymph nodes; study completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Women With Breast Cancer [Phase 3]
A Phase 3 clinical trial evaluating combination chemotherapy for treating breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy [Phase 3]
Phase 3 trial evaluating Marimastat maintenance or no further therapy in metastatic breast cancer responders/stable after chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Limited Adjuvant Endocrine Therapy for Low Risk Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating limited adjuvant endocrine therapy for low-risk breast cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: TCb vs EC-T in High Risk ER+/HER2- Breast Cancer [Phase 3]
Phase 3 clinical trial update comparing TCb versus EC-T in high-risk ER+/HER2- breast cancer; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: DP303c in Patients With HER2-positive Advanced Breast Cancer [Phase 3]
A Phase 3 clinical trial update for DP303c in HER2-positive advanced breast cancer is not yet recruiting, indicating ongoing evaluation befo…
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery [Phase 1]
Phase I trial evaluating Endoxifen Gel versus placebo in women undergoing breast surgery, including DCIS, LCIS, and various stages of breast…
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating docetaxel, carboplatin, trastuzumab, and pertuzumab with or without estrogen deprivation in hormone receptor-positi…